All Episodes

What If It’s Not Just Stress? Hormones, Menopause & Women’s Health with Sharon Lemoine, ARNP

How Cancer Uses an “Invisibility Cloak” - And How Kazia Therapeutics Is Trying to Remove It

Synthetic Lethality Explained: Targeting Cancer’s DNA Repair Weaknesses

Can T-Cell Engagers Crack Solid Tumors? The Next Frontier in Cancer Immunotherapy

Your Doctor Might Have Missed It - How AI Is Giving Cancer Patients a Second Opinion

Can Stem Cell Therapy Heal Chronic Back Pain? The Future of Regenerative Medicine

Part 2: What Is Radioligand Therapy? A New Precision Treatment for Cancer Explained

Part 1: The Radiopharmaceutical Launch Playbook: What Pharma Must Get Right Beyond the Drug

Why Fertility Care Needs to Change - And How Technology Can Help

The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic

What If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained

The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy

How Ossium Health is Changing Stem Cell Therapy and Regenerative Medicine

How Targeted Chemotherapy and Immunotherapy are Changing Cancer Care

The Future of Precision Medicine: How Biomarkers Can Guide Your Treatment

How Novartis is Changing Cancer Treatment and Putting Patients First in Modern Cancer Care

Fixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases

How to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist

A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy

Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control

How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases

Restoring Breath: Biologic Innovation for the Most Vulenerable Patients

Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy

The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies

Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer

How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly

Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt

How AI is Transforming Job Search and Recruiting in Life Sciences and Technology

From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc

From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi

How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD

The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024

How NGGT is Pioneering the Next Wave of Gene Therapies

Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

Left Behind: Addressing Health Equity for the Rare Disease Patient Community

Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

Unlocking AI In Oncology with James Zou, PhD

Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan

Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine

How MedStack helps Health Tech companies with Compliance and Data Privacy

How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System

ASCO 2024 Recap, ADCs, Cell Therapies and RLTs

ASGCT 2024 Abstracts Preview

Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics

How Ryght is Building a Generative AI Platform for BioPharma

Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar

ASGCT Annual Meeting Preview

2024 Biopharma Investment Outlook with Chris Dokomajilar

How one Survivor beat the odds against Mucosal Melanoma

Mark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes

Episode 2: Future Advances in Cell Therapy Analytics

Episode 1: Current Advancements in Cell Therapy Analytics

Health Policy Update: IRA, 340b Drug Pricing and PBMs

Special Episode: ASGCT Policy Summit Highlights

The IRA 1-year Anniversary Episode: What Lies Ahead?

Developing Best-in-Class Radiopharmaceuticals for Cancer Patients

ASGCT Policy Summit Preview

How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

How Medicenna is Developing "Superkines" as Novel Immunotherapies

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

Novel Immunotherapy approaches to engaging the Innate Immune System

Emerging Therapies for Rare Genetic Mitochondrial Diseases

Harnessing the Cell Cycle to Treat Cancer and other Serious Diseases

American Society of Gene and Cell Therapy Meeting Highlights

Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD

Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron

Erandi De Silva, PhD on Building a Gene Therapy Pipeline and Culture

Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, PhD

AACR 2023 Preview

New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD

FDA AMAT for Regenerative Medicine Therapies Workshop Recap

Don Davis, PhD, MBA on Challenges in Scaling Life Science Companies

Applications of AI and Machine Learning in BioPharma and Healthcare

A Look Ahead to 2023 Biopharma M&A, Venture Financing, Licensing and Partnerships

Biopharma Products and Companies to Watch in 2023

American Society of Hematology Highlights

Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows

How to Improve Customer Engagement in 2023

Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah

Meeting on the Mesa Roundtable Part 2: Applying "A-Cell" Concepts when Developing Cell Therapies

Meeting on the Mesa Roundtable Part 1: 'A-Cell' Principles of Quality by Design

IRA Impact on Biopharma Drug Development

OTAT Townhall Insights for Developers of Gene Therapies

Insights into the Cell and Gene Therapy Landscape

Medical Communications after the Pandemic

Best Practices in Market Access, Trade and Distribution

Chandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems

Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering

CRISPR and Gene Editing for Human Disease

The Future of Cell and Gene Therapies

Regulatory Challenges in Biotech